Search results for "CRC"

showing 10 items of 50 documents

How we treat metastatic colorectal cancer.

2020

Colorectal cancer is the second leading cause of cancer-related death worldwide. About 20% of patients suffer from metastatic disease at diagnosis, while about one-third of patients treated with curative intent relapsed. In these patients, an accurate staging allows to plan a treatment strategy within a multidisciplinary team in order to achieve predefined goals. Patient's clinical features, tumour characteristics and molecular profile (RAS/BRAF and microsatellite instability (MSI) status) should be considered during the treatment choice. Combination of chemotherapy (fluoropyrimidines, oxaliplatin and irinotecan) plus biological agents (antiepidermal growth factor receptor or antiangiogenic…

OncologyCancer Researchmedicine.medical_specialtyColorectal cancermedicine.medical_treatmentDiseaseReviewlcsh:RC254-282chemistry.chemical_compoundmCRCreviewInternal medicineRegorafenibhowitreatMedicineHumansmetastaticcolorectalcancer1506Neoplasm MetastasisUracilTipiracilChemotherapybusiness.industryMicrosatellite instabilitylcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseOxaliplatinCRCIrinotecanOxaliplatinOncologychemistrymCRCQuality of LifebusinessColorectal Neoplasmsmedicine.drugESMO open
researchProduct

Role of Densitometric Criteria in Evaluation of Effectiveness of Antiangiogenic Therapies in Metastatic Colorectal Cancer: An Italian Clinical Experi…

2017

Background/Aim: To evaluate the role of densitometric criterion using the Choi Criteria in the assessment of the response to antiangiogenic treatments of metastatic colorectal cancer (mCRC) compared to the RECIST criteria. Patients and Methods: Fifty-four patients (mean age=50.6 years ) affected by advanced colorectal cancer and with hepatic and possibly peritoneal and pulmonary metastases, that can be treated with bevacizumab, were prospectively evaluated by computerized tomography (CT) scan. Metastases were also evaluated by CT in onedimensional form according to RECIST. Results: Results show that in 58% of analyzed cases, stable disease according to RECIST coincided with stable disease a…

OncologyMalemedicine.medical_specialtyCancer ResearchBevacizumabDensitometric criteriaColorectal cancerAntiangiogenic therapyAngiogenesis InhibitorsColorectal NeoplasmAdvanced colorectal cancerStable DiseaseChoi CriteriaInternal medicinePartial responseMultidetector Computed TomographymedicineHumansDemographybusiness.industryDisease progressionLiver NeoplasmsMean ageGeneral MedicineMiddle Agedmedicine.diseaseTreatment OutcomeRECISTOncologyItalyLiver NeoplasmCHOIFemaleMetastatic colorectal cancer (mCRC)businessColorectal Neoplasmsmedicine.drugAngiogenesis InhibitorHumanDensitometryAnticancer research
researchProduct

Prognostic factors for progression-free and overall survival in advanced biliary tract cancer

2015

BACKGROUND: Biliary tract cancer is an uncommon cancer with a poor outcome. We assembled data from the National Cancer Research Institute (UK) ABC-02 study and 10 international studies to determine prognostic outcome characteristics for patients with advanced disease.METHODS: Multivariable analyses of the final dataset from the ABC-02 study were carried out. All variables were simultaneously included in a Cox proportional hazards model, and backward elimination was used to produce the final model (using a significance level of 10%), in which the selected variables were associated independently with outcome. This score was validated externally by receiver operating curve (ROC) analysis using…

Oncologymedicine.medical_specialtyDisease-Free SurvivalCholangiocarcinoma03 medical and health sciencesAdvanced diseaseCisplatin and gemcitabine0302 clinical medicineInternal medicinemedicineJournal ArticleHumansProgression-free survivalProportional Hazards ModelsPerformance statusReceiver operating characteristicManchester Cancer Research Centrebusiness.industryProportional hazards modelResearch Support Non-U.S. Gov'tResearchInstitutes_Networks_Beacons/mcrcHazard ratioArea under the curveCancerHematologymedicine.diseasePrognosisConfidence intervalSurgeryTreatment OutcomeOncologyBile Duct NeoplasmsROC Curve030220 oncology & carcinogenesisABC-02Multivariate AnalysisBiliary tract cancer030211 gastroenterology & hepatologybusinessPerformance statusPrognostic modelMeta-Analysis
researchProduct

Retrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients: A Multi-instit…

2021

INTRODUCTION: There have been significant developments in colorectal cancer (CRC) research over the last few years, with the introduction of new agents that have been prolonged median overall survival of metastatic colorectal cancer (mCRC). These therapies have improved patient outcomes; however, despite significant progress in strategies for cancer treatment, their use is limited by development of resistant mechanism. Almost 30% of patients with refractory mCRC will remain good candidates for further treatment. Regorafenib and TAS-102 are novel antitumor agents for patients with refractory mCRC. However, it is unclear which patients may derive a survival benefit from these drugs in real-li…

Oncologymedicine.medical_specialtyPyrrolidinesReal Life Clinical dataPyridinesColorectal cancerTrifluridinechemistry.chemical_compoundRefractoryInternal medicineRegorafenibmedicineHumansUracilRetrospective Studiesbusiness.industryPhenylurea CompoundsGastroenterologyRetrospective cohort studymedicine.diseaseTAS-102Disease controlCancer treatmentClinical trialDrug CombinationsOncologychemistrymCRCCohortchemorefractoryregorafenibColorectal NeoplasmsbusinessThymine
researchProduct

Shape coexistence in Hg-178

2019

Lifetime measurements of excited states in Hg-178 have been performed using the Rh-103(Kr-78, p2n) reaction at a beam energy of 354 MeV. The recoil-decay tagging (RDT) technique was applied to select the Hg-178 nuclei and associate the prompt gamma rays with the correlated characteristic ground-state alpha decay. Lifetimes of the four lowest yrast states of Hg-178 have been determined using the recoil distance Doppler-shift (RDDS) method. The experimental data are compared to theoretical predictions with focus on shape coexistence. The results confirm the shift of the deformed prolate structures to higher lying states but also indicate their increasing deformation with decreasing neutron nu…

PhysicsGEManchester Cancer Research Centre3106010308 nuclear & particles physicsYrastResearchInstitutes_Networks_Beacons/mcrcNuclear structureProlate spheroidNuclear Structure01 natural sciences114 Physical sciencesLIFETIMESPLUNGERRecoilSTATESExcited stateNeutron number0103 physical sciencesMERCURYAtomic physics010306 general physicsNuclear ExperimentBeam energy
researchProduct

Lifetime measurements in 166Re : Collective versus magnetic rotation

2016

WOS: 000371740600004

PhysicsManchester Cancer Research Centreta114010308 nuclear & particles physicsResearchInstitutes_Networks_Beacons/mcrcMagnetic rotationRouthianNuclear TheoryOrder (ring theory)Semiclassical physicsState (functional analysis)rhenium01 natural sciencesNuclear shapeRecoilExcited state0103 physical scienceslifetimesAtomic physics010306 general physicsexcited statesPhysical Review C
researchProduct

TPEN: A Triple-foil differential Plunger for lifetime measurements of excited states in Exotic Nuclei

2019

Abstract A Triple-foil differential Plunger for Exotic Nuclei (TPEN) has been developed to measure the lifetimes of excited states in nuclei with small production cross-sections. TPEN utilises one target foil and two degrader foils to make differential lifetime measurements: directly determining the decay function and its derivative at a single plunger distance setting. The direct measurement of the decay function and its derivative removes the requirement to measure γ -ray intensities at several target-to-degrader distances, thereby reducing the beam-time required relative to a conventional plunger with a single-degrader foil. This paper describes the commissioning of TPEN in the lifetime …

PlungerPhysicsNuclear and High Energy PhysicsDDCMManchester Cancer Research Centreta114ResearchInstitutes_Networks_Beacons/mcrctutkimuslaitteet156Dyplungerexcited-state lifetimestriple-foil plungerRDDSDecay functionExcited stateAtomic physicsydinfysiikkaInstrumentationFOIL method
researchProduct

Effetti dell'espressione di K-RasG12V e K-RasG13D in cellule di adenocarcinoma colorettale HT29

2013

RAS è una piccola proteina di 21kDa che si trova frequentemente mutata nei tumori. La famiglia dei geni ras consta di tre principali protoncogeni chiamati H-, K- e N-Ras. Le tre isoforme di Ras regolano la proliferazione, il differenziamento e la morte cellulare mediante l’attivazione di diversi pathways di trasduzione del segnale fra cui la cascata delle MAP chinasi e il pathway di PI3K/AKT. Le diverse isoforme di Ras attivano tutte gli stessi pathways, ma con diversa efficienza, e ciò potrebbe essere, almeno in parte, una conseguenza delle loro differenti modifiche post-traduzionali che determinano la localizzazione in specifici microdomini della membrana plasmatica. Diversi studi hanno d…

Settore BIO/06 - Anatomia Comparata E CitologiaK-Ras CRC HT29
researchProduct

Analisi dei polimorfismi dei geni codificanti per l’enzima UDP-glucuronosiltrasferasi (UGT) e per l’enzima diidropirimidina deidrogenasi (DPD), corre…

2012

Settore BIO/14 - Farmacologia5-FluorouracileDPDUGTCRC
researchProduct

Diritto all'ascolto e partecipazione dei minori non accompagnati

2021

Il contributo analizza il quadro normativo comunitario e nazionale in tema di tutela dei minori non accompagnati. In particolare, lo studio si sofferma sui profili del diritto all'ascolto, disciplinato nelle fonti internazionali e nazionali, e sulla partecipazione dei minori, anche attraverso la presentazione di un caso studio. Pur nella consapevolezza dell''intrinseca complessità della questione, si ritiene tuttavia che occorra ancora, sia a livello europeo che nazionale, una maggiore attenzione da parte dei legislatori e una visione di insieme in tema di protezione del minore, che tenga conto della peculiarità della situazione del minore migrante.

Settore IUS/01 - Diritto PrivatoSettore IUS/02 - Diritto Privato ComparatoRight to be heard Convention on the rights of the child (CRC) unaccompanied minors participation Europe Italy
researchProduct